Unresolved disorder model. using A ATOM 3846 N ACYS A 481 27.888 -46.506 -18.614 0.50 49.23 A N Unresolved disorder model. using A ATOM 3847 N BCYS A 481 27.889 -46.510 -18.617 0.50 49.20 A N Unresolved disorder model. using A ATOM 3848 CA ACYS A 481 28.641 -45.579 -17.774 0.50 48.36 A C Unresolved disorder model. using A ATOM 3849 CA BCYS A 481 28.707 -45.678 -17.739 0.50 48.23 A C Unresolved disorder model. using A ATOM 3850 C ACYS A 481 28.350 -44.138 -18.178 0.50 48.97 A C Unresolved disorder model. using A ATOM 3851 C BCYS A 481 28.537 -44.197 -18.049 0.50 48.71 A C Unresolved disorder model. using A ATOM 3852 O ACYS A 481 28.480 -43.778 -19.349 0.50 50.06 A O Unresolved disorder model. using A ATOM 3853 O BCYS A 481 28.062 -43.426 -17.215 0.50 48.27 A O Unresolved disorder model. using A ATOM 3854 CB ACYS A 481 30.140 -45.857 -17.887 0.50 48.06 A C Unresolved disorder model. using A ATOM 3855 CB BCYS A 481 30.180 -46.062 -17.875 0.50 47.97 A C Unresolved disorder model. using A ATOM 3856 SG ACYS A 481 30.585 -47.609 -17.824 0.50 48.09 A S Unresolved disorder model. using A ATOM 3857 SG BCYS A 481 30.465 -47.835 -18.043 0.50 48.16 A S Unresolved disorder model. using A ATOM 3858 N AHIS A 482 27.952 -43.315 -17.212 0.50 48.39 A N Unresolved disorder model. using A ATOM 3859 N BHIS A 482 28.932 -43.810 -19.257 0.50 49.71 A N Unresolved disorder model. using A ATOM 3860 CA AHIS A 482 27.675 -41.909 -17.493 0.50 49.01 A C Unresolved disorder model. using A ATOM 3861 CA BHIS A 482 28.906 -42.414 -19.668 0.50 50.31 A C Unresolved disorder model. using A ATOM 3862 C AHIS A 482 28.864 -41.232 -18.168 0.50 49.37 A C Unresolved disorder model. using A ATOM 3863 C BHIS A 482 30.291 -41.993 -20.145 0.50 50.43 A C Unresolved disorder model. using A ATOM 3864 O AHIS A 482 29.835 -41.893 -18.538 0.50 49.27 A O Unresolved disorder model. using A ATOM 3865 O BHIS A 482 31.298 -42.351 -19.534 0.50 49.56 A O Unresolved disorder model. using A ATOM 3866 CB AHIS A 482 27.264 -41.153 -16.224 0.50 48.27 A C Unresolved disorder model. using A ATOM 3867 CB BHIS A 482 28.449 -41.519 -18.514 0.50 49.59 A C Unresolved disorder model. using A ATOM 3868 CG AHIS A 482 27.774 -41.766 -14.957 0.50 46.96 A C Unresolved disorder model. using A ATOM 3869 ND1AHIS A 482 26.941 -42.130 -13.921 0.50 46.34 A N Unresolved disorder model. using A ATOM 3870 CD2AHIS A 482 29.028 -42.083 -14.560 0.50 46.24 A C Unresolved disorder model. using A ATOM 3871 CE1AHIS A 482 27.660 -42.641 -12.938 0.50 45.23 A C Unresolved disorder model. using A ATOM 3872 NE2AHIS A 482 28.930 -42.625 -13.301 0.50 45.28 A N Unresolved disorder model. using A ATOM 3873 N APRO A 483 28.790 -39.903 -18.324 0.50 49.90 A N Unresolved disorder model. using A ATOM 3874 N BPRO A 483 30.345 -41.224 -21.241 0.50 51.60 A N Unresolved disorder model. using A ATOM 3875 CA APRO A 483 29.782 -39.127 -19.065 0.50 50.51 A C Unresolved disorder model. using A ATOM 3876 CA BPRO A 483 31.603 -40.816 -21.841 0.50 51.95 A C Unresolved disorder model. using A ATOM 3877 C APRO A 483 31.210 -39.405 -18.611 0.50 49.64 A C Unresolved disorder model. using A ATOM 3878 C BPRO A 483 32.748 -40.825 -20.832 0.50 50.71 A C Unresolved disorder model. using A ATOM 3879 O APRO A 483 31.590 -39.039 -17.499 0.50 48.73 A O Unresolved disorder model. using A ATOM 3880 O BPRO A 483 33.665 -41.638 -20.943 0.50 50.41 A O Unresolved disorder model. using A ATOM 3881 CB APRO A 483 29.402 -37.672 -18.755 0.50 50.87 A C Unresolved disorder model. using A ATOM 3882 CB BPRO A 483 31.309 -39.388 -22.300 0.50 52.87 A C Unresolved disorder model. using A ATOM 3883 CG APRO A 483 28.496 -37.740 -17.563 0.50 50.15 A C Unresolved disorder model. using A ATOM 3884 CG BPRO A 483 29.818 -39.384 -22.591 0.50 53.63 A C Unresolved disorder model. using A ATOM 3885 CD APRO A 483 27.781 -39.042 -17.689 0.50 49.95 A C Unresolved disorder model. using A ATOM 3886 CD BPRO A 483 29.197 -40.582 -21.901 0.50 52.74 A C Unresolved disorder model. using A ATOM 3887 N AASN A 484 31.991 -40.049 -19.473 0.50 50.05 A N Unresolved disorder model. using A ATOM 3888 N BASN A 484 32.686 -39.925 -19.856 0.50 50.08 A N Unresolved disorder model. using A ATOM 3889 CA AASN A 484 33.400 -40.302 -19.193 0.50 49.46 A C Unresolved disorder model. using A ATOM 3890 CA BASN A 484 33.734 -39.810 -18.849 0.50 49.07 A C Unresolved disorder model. using A ATOM 3891 C AASN A 484 33.654 -40.656 -17.732 0.50 48.06 A C Unresolved disorder model. using A ATOM 3892 C BASN A 484 33.334 -40.428 -17.514 0.50 47.86 A C Unresolved disorder model. using A ATOM 3893 O AASN A 484 34.175 -39.843 -16.968 0.50 47.56 A O Unresolved disorder model. using A ATOM 3894 O BASN A 484 32.574 -39.836 -16.749 0.50 47.53 A O Unresolved disorder model. using A ATOM 3895 CB AASN A 484 34.243 -39.088 -19.588 0.50 50.06 A C Unresolved disorder model. using A ATOM 3896 CB BASN A 484 34.122 -38.342 -18.649 0.50 49.27 A C Unresolved disorder model. using A ATOM 3897 CG AASN A 484 34.234 -38.834 -21.084 0.50 51.53 A C Unresolved disorder model. using A ATOM 3898 CG BASN A 484 34.765 -37.734 -19.881 0.50 50.51 A C Unresolved disorder model. using A ATOM 3899 OD1AASN A 484 33.747 -37.803 -21.547 0.50 52.53 A O Unresolved disorder model. using A ATOM 3900 OD1BASN A 484 35.320 -38.444 -20.721 0.50 50.88 A O Unresolved disorder model. using A ATOM 3901 ND2AASN A 484 34.767 -39.781 -21.848 0.50 51.86 A N Unresolved disorder model. using A ATOM 3902 ND2BASN A 484 34.695 -36.412 -19.993 0.50 51.18 A N Unresolved disorder model. using A ATOM 3903 N ASER A 485 33.286 -41.875 -17.352 0.50 47.54 A N Unresolved disorder model. using A ATOM 3904 N BSER A 485 33.851 -41.621 -17.238 0.50 47.35 A N Unresolved disorder model. using A ATOM 3905 CA ASER A 485 33.478 -42.341 -15.983 0.50 46.34 A C Unresolved disorder model. using A ATOM 3906 CA BSER A 485 33.552 -42.310 -15.987 0.50 46.29 A C Unresolved disorder model. using A ATOM 3907 C ASER A 485 34.064 -43.752 -15.960 0.50 46.06 A C Unresolved disorder model. using A ATOM 3908 C BSER A 485 34.110 -43.731 -15.969 0.50 46.04 A C Unresolved disorder model. using A ATOM 3909 O ASER A 485 34.089 -44.434 -16.987 0.50 46.83 A O Unresolved disorder model. using A ATOM 3910 O BSER A 485 34.150 -44.402 -17.002 0.50 46.82 A O Unresolved disorder model. using A ATOM 3911 CB ASER A 485 32.153 -42.300 -15.217 0.50 45.93 A C Unresolved disorder model. using A ATOM 3912 CB BSER A 485 32.043 -42.326 -15.733 0.50 46.30 A C Unresolved disorder model. using A ATOM 3913 OG ASER A 485 31.653 -40.976 -15.134 0.50 46.26 A O Unresolved disorder model. using A ATOM 3914 OG BSER A 485 31.336 -42.760 -16.881 0.50 47.35 A O Unresolved disorder model. using A ATOM 7043 CA AGLN B 880 8.029 -48.095 37.619 0.50 44.04 B C Unresolved disorder model. using A ATOM 7044 CA BGLN B 880 8.035 -48.097 37.622 0.50 44.04 B C Unresolved disorder model. using A ATOM 7047 CB AGLN B 880 6.544 -48.211 37.261 0.50 44.60 B C Unresolved disorder model. using A ATOM 7048 CB BGLN B 880 6.550 -48.237 37.272 0.50 44.60 B C Unresolved disorder model. using A ATOM 7049 CG AGLN B 880 6.084 -49.609 36.880 0.50 44.13 B C Unresolved disorder model. using A ATOM 7050 CG BGLN B 880 6.085 -49.673 37.088 0.50 44.25 B C Unresolved disorder model. using A ATOM 7051 CD AGLN B 880 4.605 -49.658 36.549 0.50 44.77 B C Unresolved disorder model. using A ATOM 7052 CD BGLN B 880 6.251 -50.503 38.346 0.50 44.41 B C Unresolved disorder model. using A ATOM 7053 OE1AGLN B 880 3.839 -48.782 36.952 0.50 45.50 B O Unresolved disorder model. using A ATOM 7054 OE1BGLN B 880 6.868 -50.064 39.317 0.50 44.71 B O Unresolved disorder model. using A ATOM 7055 NE2AGLN B 880 4.197 -50.684 35.812 0.50 44.33 B N Unresolved disorder model. using A ATOM 7056 NE2BGLN B 880 5.699 -51.711 38.336 0.50 44.38 B N Unresolved disorder model. using A ATOM 8414 N APHE B1051 26.961 -50.027 33.988 0.70 38.06 B N Unresolved disorder model. using A ATOM 8415 N BPHE B1051 26.927 -50.049 33.981 0.30 37.95 B N Unresolved disorder model. using A ATOM 8416 CA APHE B1051 27.415 -51.251 33.326 0.70 37.70 B C Unresolved disorder model. using A ATOM 8417 CA BPHE B1051 27.297 -51.290 33.301 0.30 37.53 B C Unresolved disorder model. using A ATOM 8418 C APHE B1051 26.256 -52.058 32.750 0.70 37.44 B C Unresolved disorder model. using A ATOM 8419 C BPHE B1051 26.072 -52.039 32.782 0.30 37.19 B C Unresolved disorder model. using A ATOM 8420 O APHE B1051 26.371 -52.625 31.661 0.70 37.05 B O Unresolved disorder model. using A ATOM 8421 O BPHE B1051 26.180 -52.885 31.894 0.30 36.85 B O Unresolved disorder model. using A ATOM 8422 CB APHE B1051 28.210 -52.131 34.290 0.70 38.07 B C Unresolved disorder model. using A ATOM 8423 CB BPHE B1051 28.093 -52.201 34.231 0.30 37.84 B C Unresolved disorder model. using A ATOM 8424 CG APHE B1051 29.598 -51.634 34.578 0.70 38.46 B C Unresolved disorder model. using A ATOM 8425 CG BPHE B1051 29.492 -51.731 34.493 0.30 38.20 B C Unresolved disorder model. using A ATOM 8426 CD1APHE B1051 29.965 -51.287 35.872 0.70 39.18 B C Unresolved disorder model. using A ATOM 8427 CD1BPHE B1051 29.904 -51.424 35.778 0.30 38.86 B C Unresolved disorder model. using A ATOM 8428 CD2APHE B1051 30.543 -51.533 33.564 0.70 38.04 B C Unresolved disorder model. using A ATOM 8429 CD2BPHE B1051 30.398 -51.599 33.456 0.30 37.90 B C Unresolved disorder model. using A ATOM 8430 CE1APHE B1051 31.248 -50.834 36.154 0.70 39.48 B C Unresolved disorder model. using A ATOM 8431 CE1BPHE B1051 31.191 -50.994 36.024 0.30 39.20 B C Unresolved disorder model. using A ATOM 8432 CE2APHE B1051 31.825 -51.081 33.835 0.70 38.44 B C Unresolved disorder model. using A ATOM 8433 CE2BPHE B1051 31.684 -51.169 33.696 0.30 38.27 B C Unresolved disorder model. using A ATOM 8434 CZ APHE B1051 32.179 -50.732 35.133 0.70 39.17 B C Unresolved disorder model. using A ATOM 8435 CZ BPHE B1051 32.082 -50.866 34.982 0.30 38.93 B C Unresolved disorder model. using A ATOM 8451 N ALEU B1052 22.796 -51.617 32.417 0.70 38.10 B N Unresolved disorder model. using A ATOM 8452 N BLEU B1052 22.887 -51.194 32.550 0.30 38.26 B N Unresolved disorder model. using A ATOM 8453 CA ALEU B1052 21.936 -50.871 31.447 0.70 38.10 B C Unresolved disorder model. using A ATOM 8454 CA BLEU B1052 21.946 -50.773 31.471 0.30 38.10 B C Unresolved disorder model. using A ATOM 8455 C ALEU B1052 22.577 -50.823 30.062 0.70 37.74 B C Unresolved disorder model. using A ATOM 8456 C BLEU B1052 22.585 -50.874 30.088 0.30 37.71 B C Unresolved disorder model. using A ATOM 8457 O ALEU B1052 21.886 -50.946 29.048 0.70 37.63 B O Unresolved disorder model. using A ATOM 8458 O BLEU B1052 21.900 -51.150 29.100 0.30 37.52 B O Unresolved disorder model. using A ATOM 8459 CB ALEU B1052 21.628 -49.460 31.959 0.70 38.55 B C Unresolved disorder model. using A ATOM 8460 CB BLEU B1052 21.450 -49.348 31.720 0.30 38.50 B C Unresolved disorder model. using A ATOM 8461 CG ALEU B1052 20.732 -49.360 33.200 0.70 39.12 B C Unresolved disorder model. using A ATOM 8462 CG BLEU B1052 20.686 -49.126 33.026 0.30 39.05 B C Unresolved disorder model. using A ATOM 8463 CD1ALEU B1052 20.875 -47.999 33.853 0.70 39.65 B C Unresolved disorder model. using A ATOM 8464 CD1BLEU B1052 20.309 -47.663 33.181 0.30 39.56 B C Unresolved disorder model. using A ATOM 8465 CD2ALEU B1052 19.270 -49.649 32.872 0.70 39.11 B C Unresolved disorder model. using A ATOM 8466 CD2BLEU B1052 19.450 -50.012 33.081 0.30 39.01 B C 1